Early SRC activation skews cell fate from apoptosis to senescence
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Cells responding to DNA damage implement complex adaptive programs that often culminate in one of two distinct outcomes: apoptosis or senescence. To systematically identify factors driving each response, we analyzed human IMR-90 fibroblasts exposed to increasing doses of the genotoxin etoposide and identified SRC as a key kinase contributing early to this dichotomous decision. SRC was activated by low but not high levels of etoposide. With low DNA damage, SRC-mediated activation of p38 critically promoted expression of cell survival and senescence proteins, while SRC-mediated repression of p53 prevented a rise in proapoptotic proteins. With high DNA damage, failure to activate SRC led to elevation of p53, inhibition of p38, and apoptosis. In mice exposed to DNA damage, pharmacologic inhibition of SRC prevented the accumulation of senescent cells in tissues. We propose that inhibiting SRC could be exploited to favor apoptosis over senescence in tissues to improve health outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“we set the strict requirement that minimal or no cell death was seen to avoid noise from other forms of damage response such as apoptosis.21–23”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [22]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814
Gene set knowledge discovery with enrichr
Xie, Z., Bailey, A., Kuleshov, M. V., Clarke, D. J. B., Evangelista, J. E., Jenkins, S. L., Lachmann, A., Wojciechowicz, M. L., Kropiwnicki, E., Jagodnik, K. M., et al. (2021) · Current Protocols · doi:10.1002/cpz1.90 · Cited by 3,451
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
Wound Healing: A Cellular Perspective
Rodrigues, M., Kosaric, N., Bonham, C. A., & Gurtner, G. C. (2019) · Physiological Reviews · doi:10.1152/physrev.00067.2017 · Cited by 3,013
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
Singh, R., Letai, A., & Sarosiek, K. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0089-8 · Cited by 2,111
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819
Signaling mechanisms of the epithelial-mesenchymal transition
Gonzalez, D. M., & Medici, D. (2014) · Science Signaling · doi:10.1126/scisignal.2005189 · Cited by 1,721
Humphries, J. D., Byron, A., & Humphries, M. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03098 · Cited by 1,708
Baar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois, B. R. M., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.031 · Cited by 1,454
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression
Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J., & Strasser, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.169 · Cited by 1,395
Cellular senescence promotes adverse effects of chemotherapy and cancer relapse
Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0241 · Cited by 1,338 · cited 3×
“Chemotherapyinduced senescence of nonmalignant cells is an example of cellular senescence that has proven to be quite harmful (14).”
BackgroundMethodInfluentialSenescence and aging: Causes, consequences, and therapeutic avenues
McHugh, D., & Gil, J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708092 · Cited by 1,233
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186
The multiple mechanisms that regulate p53 activity and cell fate
Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0110-x · Cited by 1,129
Cellular senescence drives age-dependent hepatic steatosis
Ogrodnik, M., Miwa, S., Tchkonia, T., Tiniakos, D., Wilson, C. L., Lahat, A., Day, C. P., Burt, A., Palmer, A., Anstee, Q. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15691 · Cited by 1,044
Freund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039 · cited 1×
“In senescence, p38 likely favors cell survival by promoting autophagy (20), and perhaps by activating pathways such as those that increase NF-B activity (49) or augment p21 expression levels (16).”
BackgroundDirected elimination of senescent cells by inhibition of BCL-W and BCL-XL
Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11190 · Cited by 1,032
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Senescence and apoptosis: dueling or complementary cell fates?
Childs, B. G., Baker, D. J., Kirkland, J. L., Campisi, J., & van Deursen, J. M. (2014) · The EMBO Reports · doi:10.15252/embr.201439245 · Cited by 915
Chronic inflammation induces telomere dysfunction and accelerates ageing in mice
Jurk, D., Wilson, C., Passos, J. F., Oakley, F., Correia-Melo, C., Greaves, L., Saretzki, G., Fox, C., Lawless, C., Anderson, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5172 · Cited by 819
Src kinases as therapeutic targets for cancer
Kim, L. C., Song, L., & Haura, E. B. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.129 · Cited by 700
Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors
Roskoski, R. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.01.003 · Cited by 607
NOTCH1 mediates a switch between two distinct secretomes during senescence
Hoare, M., Ito, Y., Kang, T.-W., Weekes, M. P., Matheson, N. J., Patten, D. A., Shetty, S., Parry, A. J., Menon, S., Salama, R., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3397 · Cited by 522
Nuclear FAK Promotes Cell Proliferation and Survival through FERM-Enhanced p53 Degradation
Lim, S.-T., Chen, X. L., Lim, Y., Hanson, D. A., Vo, T.-T., Howerton, K., Larocque, N., Fisher, S. J., Schlaepfer, D. D., & Ilic, D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.11.031 · Cited by 480
Yosef, R., Pilpel, N., Papismadov, N., Gal, H., Ovadya, Y., Vadai, E., Miller, S., Porat, Z., Ben‐Dor, S., & Krizhanovsky, V. (2017) · The EMBO Journal · doi:10.15252/embj.201695553 · Cited by 293
The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review
Zhou, J., Yi, Q., & Tang, L. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1265-1 · Cited by 287
Bird, T. G., Müller, M., Boulter, L., Vincent, D. F., Ridgway, R. A., Lopez-Guadamillas, E., Lu, W.-Y., Jamieson, T., Govaere, O., Campbell, A. D., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan1230 · Cited by 261
Integrins Play a Critical Role in Mechanical Stress–Induced p38 MAPK Activation
Aikawa, R., Nagai, T., Kudoh, S., Zou, Y., Tanaka, M., Tamura, M., Akazawa, H., Takano, H., Nagai, R., & Komuro, I. (2002) · Hypertension · doi:10.1161/hy0202.102699 · Cited by 207
Integrin Beta 3 Regulates Cellular Senescence by Activating the TGF-β Pathway
Rapisarda, V., Borghesan, M., Miguela, V., Encheva, V., Snijders, A. P., Lujambio, A., & O’Loghlen, A. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.012 · Cited by 190
The Stress Kinase p38α as a Target for Cancer Therapy
Igea, A., & Nebreda, A. R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0173 · Cited by 189
Cellular Senescence Limits Regenerative Capacity and Allograft Survival
Braun, H., Schmidt, B. M. W., Raiss, M., Baisantry, A., Mircea-Constantin, D., Wang, S., Gross, M.-L., Serrano, M., Schmitt, R., & Melk, A. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011100967 · Cited by 179
Regulation of Survival Networks in Senescent Cells: From Mechanisms to Interventions
Soto-Gamez, A., Quax, W. J., & Demaria, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.05.036 · Cited by 175
Senescence in chronic liver disease: Is the future in aging?
Aravinthan, A. D., & Alexander, G. J. M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.030 · Cited by 174
Regulation of senescence traits by MAPKs
Anerillas, C., Abdelmohsen, K., & Gorospe, M. (2020) · GeroScience · doi:10.1007/s11357-020-00183-3 · Cited by 166
Self-citationEfeyan, A., Ortega-Molina, A., Velasco-Miguel, S., Herranz, D., Vassilev, L. T., & Serrano, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0200 · Cited by 140 · cited 1×
“We used AL 8697, a potent and selective inhibitor of p38 (p38i) (22), and Nutlin-3a, a strong inhibitor of the interaction between MDM2 and p53 that renders p53 stable and active (p53a) (23).”
MethodBCL-w: apoptotic and non-apoptotic role in health and disease
Hartman, M. L., & Czyz, M. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2417-0 · Cited by 108
Ritschka, B., Knauer-Meyer, T., Gonçalves, D. S., Mas, A., Plassat, J.-L., Durik, M., Jacobs, H., Pedone, E., Di Vicino, U., Cosma, M. P., et al. (2020) · Genes & Development · doi:10.1101/gad.332643.119 · Cited by 105
Autophagy-induced senescence is regulated by p38α signaling
Slobodnyuk, K., Radic, N., Ivanova, S., Lladó, A., Trempolec, N., Zorzano, A., & Nebreda, Á. R. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1607-0 · Cited by 97
Cell-to-Cell Heterogeneity in p38-Mediated Cross-Inhibition of JNK Causes Stochastic Cell Death
Miura, H., Kondo, Y., Matsuda, M., & Aoki, K. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.020 · Cited by 94
Integrin-mediated adhesions in regulation of cellular senescence
Shin, E., Park, J., You, S.-T., Lee, C., Won, S.-Y., Park, J.-J., Kim, H.-B., Shim, J., Soung, N., Lee, O.-J., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay3909 · Cited by 92
Differential transformation capacity of Src family kinases during the initiation of prostate cancer
Cai, H., Smith, D. A., Memarzadeh, S., Lowell, C. A., Cooper, J. A., & Witte, O. N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103904108 · Cited by 89
p38 MAPK Controls Prothrombin Expression by Regulated RNA 3′ End Processing
Danckwardt, S., Gantzert, A.-S., Macher‐Goeppinger, S., Probst, H. C., Gentzel, M., Wilm, M. S., Gröne, H., Schirmacher, P., Hentze, M. W., & Kulozik, A. E. (2011) · Molecular Cell · doi:10.1016/j.molcel.2010.12.032 · Cited by 79
Ohtani, N., Imamura, Y., Yamakoshi, K., Hirota, F., Nakayama, R., Kubo, Y., Ishimaru, N., Takahashi, A., Hirao, A., Shimizu, T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706949104 · Cited by 73
Seo, H.-Y., Lee, S. H., Lee, J.-H., Kang, Y. N., Hwang, J. S., Park, K., Kim, M. K., & Jang, B. K. (2020) · Cells · doi:10.3390/cells9030558 · Cited by 64
Literature-based automated discovery of tumor suppressor p53 phosphorylation and inhibition by NEK2
Choi, B.-K., Dayaram, T., Parikh, N., Wilkins, A. D., Nagarajan, M., Novikov, I. B., Bachman, B. J., Jung, S. Y., Haas, P. J., Labrie, J. L., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806643115 · Cited by 58
Src-family tyrosine kinases and the Ca2+ signal
Anguita, E., & Villalobo, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.10.022 · Cited by 57
FAK and p53 Protein Interactions
Golubovskaya, V., & Cance, W. G. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011796817619 · Cited by 51
Kim, M., Byun, J., Yun, C.-H., Park, I., Lee, K.-H., & Lee, S. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0084 · Cited by 50
Jung, S. H., Lee, M., Park, H. A., Lee, H., Kang, D., Hwang, H. J., Park, C., Yu, D., Jung, Y. R., Mi-Na, H. O. N. G., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0114-7 · Cited by 50
Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease
Lakhani, H. V., Sharma, D. L., Dodrill, M. W., Nawab, A., Sharma, N., Cottrill, C. L., Shapiro, J. I., & Sodhi, K. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.27953 · Cited by 48
Barretta, M. L., Spano, D., DˈAmbrosio, C., Cervigni, R. I., Scaloni, A., Corda, D., & Colanzi, A. (2016) · Nature Communications · doi:10.1038/ncomms11727 · Cited by 43
To C or not to C: Direct and indirect redox regulation of Src protein tyrosine kinase
Sun, G., & Kemble, D. J. (2009) · Cell Cycle · doi:10.4161/cc.8.15.9225 · Cited by 37
Src kinase modulates the apoptotic p53 pathway by altering HIPK2 localization
Polonio-Vallon, T., Kirckpatrick, J., Krijgsveld, J., & Hofmann, T. G. (2013) · Cell Cycle · doi:10.4161/cc.26857 · Cited by 37
Integrin α9 regulates smooth muscle cell phenotype switching and vascular remodeling
Jain, M. K., Dev, R., Doddapattar, P., Kon, S., Dhanesha, N., & Chauhan, A. K. (2021) · JCI Insight · doi:10.1172/jci.insight.147134 · Cited by 35
Ryu, S. J., Cho, K., Oh, Y. S., & Park, S. C. (2006) · APOPTOSIS · doi:10.1007/s10495-006-3978-9 · Cited by 33
Novel triazolopyridylbenzamides as potent and selective p38α inhibitors
Aiguadé, J., Balagué, C., Carranco, I., Caturla, F., Domínguez, M., Eastwood, P. R., Esteve, C., González, J., Lumeras, W., Orellana, A., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.03.099 · Cited by 32
Wei, C., Li, L., Menon, M. C., Zhang, W., Fu, J., Kidd, B. A., Keung, K. L., Woytovich, C., Greene, I., Xiao, W., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016020238 · Cited by 32
Herman, A. B., Anerillas, C., Harris, S. C., Munk, R., Martindale, J. L., Yang, X., Mazan-Mamczarz, K., Zhang, Y., Heckenbach, I. J., Scheibye-Knudsen, M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab538 · Cited by 31
Self-citationAspinall, R., Weis, S. M., Barnes, L. A., Lutu-Fuga, K. M., Bylund, D. J., Pockros, P. J., & Cheresh, D. A. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02554.x · Cited by 14
Cited by
Therapeutic targeting of senescent cells in the CNS
Riessland, M., Ximerakis, M., Jarjour, A. A., Zhang, B., & Orr, M. E. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01033-z · Cited by 77
The YAP-TEAD complex promotes senescent cell survival by lowering endoplasmic reticulum stress
Anerillas, C., Mazan-Mamczarz, K., Herman, A. B., Munk, R., Lam, K.-W. G., Calvo-Rubio, M., Garrido, A., Tsitsipatis, D., Martindale, J. L., Altés, G., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00480-4 · Cited by 76
Self-citationRole of c-Src in Carcinogenesis and Drug Resistance
Raji, L. M., Tetteh, A., & Amin, A. R. M. R. (2023) · Cancers · doi:10.3390/cancers16010032 · Cited by 75
Li, Y., Li, C., Zhou, Q., Liu, X., Qiao, Y., Xie, T., Sun, H., Ong, M. T., & Wang, H. (2025) · Nature Communications · doi:10.1038/s41467-025-61403-y · Cited by 72
DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice
Herman, A. B., Tsitsipatis, D., Anerillas, C., Mazan-Mamczarz, K., Carr, A. E., Gregg, J. M., Wang, M., Zhang, J., Michel, M., Henry-Smith, C. A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165933 · Cited by 50
“Surprisingly, the levels of mRNAs encoding complement and matrix remodeling factors (C2, C5, CFB, CFD, imaged and counted cells 48 hours after Doxo treatment, a time frame in which cell-fate decisions between senescence and apoptosis are apparent (34).”
Self-citation
Metadata
- Authors
- Anerillas, C., Herman, A. B., Rossi, M., Munk, R., Lehrmann, E., Martindale, J. L., Cui, C.-Y., Abdelmohsen, K., De, S., & Gorospe, M.
- Affiliations
- National Institute on Aging (US)
- Corresponding author
- Anerillas, Carlos
- Gorospe, Myriam
- ORCID
- Venue
- Science Advances
- Published
- 2022-04-08
- Volume
- 8
- Issue
- 14
- Pages
- eabm0756-eabm0756
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC8993123
- OpenAlex
- W4223486770
- Cited by
- 71
- References
- 63
- Citations by year
- 2026: 19 · 2025: 15 · 2024: 18 · 2023: 14 · 2022: 5
- FWCI
- 8.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1z01ag000511-08, Z01-AG000511)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Src kinase, DNA damage response, cellular senescence, apoptosis, p38 MAPK, p53, etoposide, IMR-90 fibroblasts, Src kinase inhibition
- MeSH terms
- Animals, DNA Damage, Etoposide, Fibroblasts, Tumor Suppressor Protein p53, Cellular Senescence, Apoptosis, src-Family Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.